✦ LIBER ✦

DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses

✍ Scribed by Belen Borrego; Paloma Fernandez-Pacheco; Llilianne Ganges; Nieves Domenech; Natalia Fernandez-Borges; Francisco Sobrino; Fernando Rodríguez

Book ID: 116958781
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 339 KB
Volume: 24
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.02.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of the B-cell and T-cell epit

Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice

✍ Flávia W. da Cruz; Alan J.A. McBride; Fabrı́cio R. Conceição; Jeremy W. Dale; Jo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Protective CTL response is induced in th

Protective CTL response is induced in the absence of CD4+ T cells and IFN-γ by gene gun DNA vaccination with a minigene encoding a CTL epitope of Listeria monocytogenes

✍ Atsushi Yoshida; Toshi Nagata; Masato Uchijima; Yukio Koide 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Plasmid DNA and protein vaccination of m

Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo

✍ Weimin Zhong; Karl-Heinz Wiesmüller; Michael D. Kramer; Reinhard Wallich; Markus 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 945 KB

Lessons from IAVI-006, a Phase I clinica

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Corrigendum to “Lessons from IAVI-006, a

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 91 KB